Takeda acquisition of Shire : Japanese pharma company Takeda Pharmaceutical wrapped up its previously announced acquisition of Shire, an Irish biotech company with a focus on rare diseases, for $62 billion, as per the latest pharma acquisition news. Takeda acquisition of Shire It was in May 2018 when Takeda agreed to acquire the Irish rare […]
Continue reading …Astellas acquisition of Potenza : Japanese pharma company Astellas Pharma has exercised an option to acquire US-based Potenza Therapeutics in a deal worth up to $404.7 million. The acquisition is a result of a collaboration agreement signed by the two pharma companies in 2015 to develop a portfolio of novel immuno-oncology (IO) therapies. In the […]
Continue reading …